Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

International, Multicentric, Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Who May Be Eligible (Plain English)

Who May Qualify: - Participants previously diagnosed with ASD (DSM-5) - Available well-documented health records within the first 2 years of life - Participants must have a parent or reliable caregiver who agrees to provide information about the participant - Participants willing and consenting or assenting to participate. Who Should NOT Join This Trial: - Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment. - If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Participants previously diagnosed with ASD (DSM-5) * Available well-documented health records within the first 2 years of life * Participants must have a parent or reliable caregiver who agrees to provide information about the participant * Participants willing and consenting or assenting to participate. Exclusion Criteria: * Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment. * If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.

Locations (20)

SARRC
Phoenix, Arizona, United States
California Neuroscience Research
Sherman Oaks, California, United States
BioPhase Research
Miami, Florida, United States
The Angel Medical Research
Miami Lakes, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders
Columbia, Missouri, United States
Golden Hearts Diagnostic
Alamogordo, New Mexico, United States
Red Oak Psychiatry Associates
Houston, Texas, United States
Alpine Research Organization
Clinton, Utah, United States
Children's Health Queensland Hospital and Health Service
South Brisbane, Queensland, Australia
Mater Misericordiae Limited
South Brisbane, Queensland, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
Locuspsych
Melbourne, Victoria, Australia
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Hospital General Universitario Dr Balmis
Alicante, Spain
Hospital Clinic of Barcelona
Barcelona, Spain
Hospital Infantil Universitario Nino Jesus (HIUNJS)
Madrid, Spain
Hospital universitario Infanta Leonor
Madrid, Spain
Hospital Universitario Puerta De Hierro Majadahonda
Majadahonda, Spain
Policlina Gipuzkoa
San Sebastián, Spain